Abstract-The
Abstract-The effects of newly synthesized 5-imidazoline derivatives on the dose response relationship to norepinephrine were investigated in the normal and denervated vasa deferentia of the rat. Three derivatives (K-3827, K-401 1 and K-4300) exerted a-antagonistic action, the potency of which was similar to that of tolazoline.
The pA2 values of these derivatives and currently known a antagonists (tolazoline, phentolamine and prazosin, but not yohimbine) in the denervated tissue were slightly but significantly larger than those in the normal tissue.
All imidazoline derivatives and a-antagonists produced an increase in the maximum response to norepinephrine in the normal vas deferens.
In the denervated tissue, however, K-3827, K-4011 and a-antagonists caused only a rightward shift of the dose-response curve to norepinephrine, but not an increase in the maximum response, i.e., relatively pure a-antagonism.
In contrast, the other 3 imidazoline derivatives, K-4299 and K-6342 which exhibited neither a-agonistic nor antagonistic action and K-4300, increased the maximum response to norepinephrine even after denervation. Their effects were nonspecific in that they also potentiated acetyl choline-induced contractions in both normal and denervated tissues. These 3 im dazoline derivatives antagonized the action of diltiazem. The effects of imidazoline derivatives and a-antagonists were discussed in relation to those of denervation, and the drug enhancement by 3 imidazoline derivatives was analyzed from the viewpoint of calcium movement.
Supersensitivity
in smooth muscle which is due to actual changes in the responsiveness of smooth muscle cells has been referred to as postjunctional supersensitivity (1) (2) (3) . Post junctional supersensitivity in the rat vas deferens induced by surgical or chemical denervation was found to be accompanied by a large increase in the maximum response to various excitatory drugs (4) (5) (6) (7) . It has been demonstrated also in the rat vas deferens that reversible a-adrenoceptor antagonists, phen tolamine, yohimbine, tolazoline, etc. caused an increase in the maximum response to norepinephrine as well as an antagonism to norepinephrine (8, 9). We previously intro duced new imidazoline derivatives and performed pharmacological analysis with special emphasis on their action on postsyn aptic a, and presynaptic a2-adrenoceptors in the rat vas deferens (10).
Among these imidazoline derivatives, 5 compounds produced a significant enhance ment of the maximum response to noreine phrine.
In the present study, the drug enhancement was precisely compared in the normal and denervated rat vasa deferentia. Because some of the imidazoline derivatives exhibited a-antagonistic action, the effects of currently known a-antagonists were comparatively investigated. The mechanisms of drug enhancement were discussed in con nection with postjunctional alterations of the smooth muscle of the rat vas deferens induced by denervation. Fig. 1 at an interval of 30 min. The tissue was exposed to the test drug for 5 min and then subjected to the determination of the dose-response curve to agonists. It was confirmed in advance that there were no appreciable differences in the dose-response curves to agonists repeatedly obtained for 3-4 times at an interval of 30 min in the same preparation.
When a calcium antagonist was used, it was applied to the tissue 10 min before starting the similar determination of dose response curves to agonists as described above.
Drugs used: In the present study, the following drugs were used: tolazoline hydrochloride (Fluka), yohimbine hydro chloride (Wako), phentolamine mesylate (Ciba-Geigy), prazosin hydrochloride (Pfizer), diltiazem hydrochloride (Tanabe), L-norepinephrine bitartrate (Wako) and acetylcholine chloride (Tokyo kasei).
Structural formulas of the new imidazoline derivatives are collectively presented in Fig. 1 .
Statistics: pA2 values were calculated according to the method of van Rossum (11). Statistical evaluation of the results was made by Student's t-test. Differences with P values less than 0.01 were considered to be significant. That is, they produced rightward shift of the dose-response curve to norepinephrine.
The pA2 values of these derivatives against norepinephrine are pre sented in Table 1 . The other derivatives, K 6342 and K-4299, showed neither a-agonistic nor a-antagonistic action. All imidazoline derivatives increased the maximum response to norepinephrine in the normal tissue. When the absolute length of the maximum isotonic contraction to norepinephrine was carefully compared between the normal and denervated vasa deferentia (9 pairs), the ratio was 1.59±0.13 (Denervated/Normal). That is, the maximum response to norepine phrine has already been increased by ap proximately 60% by denervation.
In the denervated vas deferens, K-401 1 and K-3827 caused only a rightward shift of the dose-response curve to norepinephrine nearly in a parallel fashion. However, K-4300 produced not only a rightward shift of the dose-response curve, but also an increase in the maximum response to norepinephrine.
In contrast, K-6342 and K-4299 produced only an increase in maximum at relatively high concentrations in the denervated tissue. The effects of all imidazoline derivatives on the maximum response to norepinephrine in both normal and denervated tissues are collectively shown in Table 2 . Figure  4 shows the effects of 3 imidazoline derivatives on the dose-response curves to acetylcholine in the normal and denervated tissues.
As can be seen, all of these derivatives enhanced acetylcholine-induced contractile responses in both tissues.
The effect of K-4300 was most remarkable. Figure  5 shows that the suppressing action of diltiazem on norepine phrine-induced contraction was markedly diminished by either of the 3 imidazoline derivatives. produced a rightward shift of the dose response curve to norepinephrine in the normal rat vas deferens, indicating that these derivatives showed an a-antagonistic action which was similar in potency to that of tolazoline. In addition to the a-antagonistic action, all 3 imidazoline derivatives at relatively high concentrations induced a significant increase in the maximum response to norepinephrine.
A qualitatively similar effect on the dose-response curve to nore pinephrine was also detected with currently well-known a-antagonists employed in the present study (tolazoline, phentolamine, yohimbine and prazosin). Prazosin is a so called specific postsynaptic a,-antagonist, and yohimbine is a relatively specific presynaptic a2-antagonist in the rat vas deferens (12, 13). When considering the potency of the antagonizing action (pA2  values) of all these compounds against norepinephrine at a, and a2-adrenoceptors in the rat vas deferens (10, 13), the maximum response-increasing effect appears to be Each point is the mean of 6-8 experiments.
somewhat correlated to their a, -antagonistic action, but not to a2-antagonistic action. At present, however, it is still obscure whether the increase in the maximum is due to a antagonistic action itself. response curve to norepinephrine, but not an increase in the maximum response. It can be easily supposed that the neuronal uptake of norepinephrine disappears inevitably follow ing surgical denervation of the tissue. Some drugs which increase the maximum response to norepinephrine have been known to inhibit norepinephrine uptake into adrenergic neurons (14, 15). However, the maximum response-increasing action does not correlate well with their relative ability to inhibit the uptake of norepinephrine (16). Thus, the inhibition of uptake does not seem to account for the ability of these drugs to increase maximal response to norepinephrine.
The pA2 value of K-401 1, K-3827, K-4300 and a-antagonists except for yohimbine in the control vas deferens was a little but significantly smaller than that in the denervated tissue, suggesting that the affinity of a-antagonistic compounds to postsynaptic a1-adrenoceptor apparently in creased after denervation. However, it may be virtually meaningless to strictly compare the pA2 values of a-antagonistic compounds in the control vas deferens to those in the denervated tissue for the following reason. In the control vas deferens, as described above, K-4300, K-401 1, K-3827 and all a antagonists potentiated the responses to high concentrations of norepinephrine. Naturally, these effects would counteract their a antagonistic action on postsynaptic a, adrenoceptor, thereby resulting in a leftward retreat of the dose-response curve to nore pinephrine. It is thus quite likely that even if the affinity of these a-antagonistic com pounds to postsynaptic a,-adrenoceptor is not appreciably changed by denervation, their pA2 values in the control tissue would appear to have smaller values compared with those in the denervated tissue. Therefore, only a small difference in pA2 values of a antagonistic compounds between the control and denervated tissues as shown in Table 1 would not imply that denervation caused a significant alteration in the affinity of a adrenoceptors to drugs. This is compatible with the fact that no change has been demonstrated in the affinity of a-adre noceptors for drugs associated with postjunctional supersensitivity (16, 17).
Multiple cellular changes are possibly contributing to postjunctional supersensitivity and the change which is the most important component varies from tissue to tissue. In smooth muscle, alterations in the membrane electrical properties (18-21), in the mem brane Na+,K+ pump activities (22, 23) and in the calcium metabolism (24) have been demonstrated to be most extensively responsible for postjunctional supersensitivity. Because the maximum-increasing effects of K-4011, K-3827 and the 4 a-antagonists completely disappeared after denervation, one or more components of the mechanisms described above would presumably be con tributing to these compounds-induced in crease in the maximum response to nor epinephrine.
The fact that K-4299, K-4300 and K-6342 produced a further increase in the response to high concentrations of norepinephrine in the denervated tissue is extremely surprising because such a phenomenon has never been demonstrated. These 3 imidazoline derivatives are therefore assumed to be novel compounds possessing different characteristics from other imidazoline derivatives and a-adre noceptor antagonists. The effect of K-4300 appeared to be particularly potent, ir respective of exhibiting a-antagonistic action. Although K-4011 and K-3827 did not possess nonspecific action, the action of the 3 imidazoline derivatives was non specific since they also potentiated the acetylcholine-induced contractile response in both normal and denervated tissues. In this case, the effect of K-4300 was again potent. A contribution of the cholinesterase inhibiting action of these derivatives to the enhancement of acetylcholine-induced con traction is also conceivable (K. Takeuchi, unpublished observation). These 3 imi dazoline derivatives at high concentrations increased the maximum response to nor epinephrine even in the presence of diltiazem, a powerful calcium antagonist. The con tractile response to agents of the rat vas deferens is generally dependent on ex tracellular calcium ion (25). Therefore, it can be suggested that K-4299, K-4300 and K-6342 would have an enhancing action on norepinephrine-induced influx of extracellular calcium, in addition to the actions mecha nisms of which are probably in common to those of denervation.
The precise mechanisms are now under investigation in our laboratories
